Skip to main content
. 2023 Sep 7;29(4):356–363. doi: 10.1093/oncolo/oyad237

Figure 1.

Figure 1.

Researcher experience and comfort with TM/RPM in phase I and phase II/III trials. (A) represents the frequencies of clinical researcher experience (light blue) and comfort (dark blue) with TM/RPM in phase I clinical trials. (B) represents the frequencies of clinical researcher experience (light green) and comfort (dark green) with TM/RPM in phase II/III clinical trials.